- Nov 11, 2019
- 10,603
- 394
- 0
The FDA is helping to speed up the process of developing and approving a drug based on psilocybin, a hallucinogenic substance in magic mushrooms, to treat depression.
FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression : Read more
FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression : Read more